GBA1 and Parkinson disease: Although not a gene-specific therapy in the narrow sense, the response to deep brain stimulation might vary depending on the underlying genotype.31 In addition, the postoperative risk of developing dementia appears to be higher in GBA1-PD than in other genetic forms, which could be included in future treatment guidelines to identify suitable candidates for deep brain stimulation and to predict the postoperative outcome better.32